Experimental Alzheimer’s Drug Effective, Safe

Published on October 29, 2024

Coya Therapeutics said on Tuesday its experimental Alzheimer’s drug was safe and increased levels of a type of immune cells that help prevent neuroinflammation in patients with Alzheimer’s disease enrolled in a small, mid-stage trial. The antibody drug COYA 301, part of the…

Read Full Article (External Site)